CLOSED-CIRCUIT ANESTHESIA WITH SEVOFLURANE IN HUMANS - EFFECTS ON RENAL AND HEPATIC-FUNCTION AND CONCENTRATIONS OF BREAKDOWN PRODUCTS WITH SODA LIME IN THE CIRCUIT

被引:96
作者
BITO, H [1 ]
IKEDA, K [1 ]
机构
[1] HAMAMATSU UNIV HOSP, HAMAMATSU, SHIZUOKA, JAPAN
关键词
ANESTHETICS; VOLATILE SEVOFLURANE; CARBON DIOXIDE; ABSORPTION; SODA LIME; EQUIPMENT; ANESTHETIC SYSTEM; CLOSED-CIRCUIT;
D O I
10.1097/00000542-199401000-00014
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Sevoflurane reacts with CO, absorbents, resulting in the generation of breakdown products. The concentrations of sevoflurane breakdown products in a low-flow system within 5 h have been reported, but concentrations in low-flow anesthesia exceeding 5 h or in closed-circuit anesthesia have not. In this study, the breakdown products of sevoflurane in closed-circuit anesthesia exceeding 5 h were examined. Methods: Closed-circuit sevoflurane anesthesia was administered to ten patients. Laboratory tests of hepatic and renal function were performed before and after anesthesia. Gas samples were obtained from the inspiratory limb of the anesthesia circuit, and breakdown products were analyzed by gas chromatography. The temperature of the soda lime was measured during anesthesia. Results: Among the breakdown products of sevoflurane, two products, CF2=C(CF3)-O-CH2F (compound A) and CH3OCF2CH(CF3)OCH2F (compound B), were detected. Compound A was detected in all measurements, and its concentration reached 19.5+/-5.4 ppm 1 h after anesthesia and decreased after 5 h. The highest concentration observed for compound A was 30.0 ppm. Compound B was detected in seven of the ten patients; its concentration was 0.17+/-0.37 ppm after 0.5 h of anesthesia and remained at similar concentrations thereafter. The highest mean temperature of the soda lime was 46.0+/-1.7 degrees C. Postanesthetic clinical laboratory tests showed no abnormalities in hepatic or renal function associated with anesthesia. Conclusions: Two breakdown products were detected in the patients anesthetized with sevoflurane using a closed-circuit technique. No abnormalities were observed during anesthesia, and no evidence of hepatic or renal dysfunction was noted in postoperative laboratory tests.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 10 条
[1]   QUANTIFICATION OF THE DEGRADATION PRODUCTS OF SEVOFLURANE IN 2 CO2 ABSORBANTS DURING LOW-FLOW ANESTHESIA IN SURGICAL PATIENTS [J].
FRINK, EJ ;
MALAN, TP ;
MORGAN, SE ;
BROWN, EA ;
MALCOMSON, M ;
BROWN, BR .
ANESTHESIOLOGY, 1992, 77 (06) :1064-1069
[2]  
HANAKI C, 1987, Hiroshima Journal of Medical Sciences, V36, P61
[3]  
Kudo M, 1990, Masui, V39, P39
[4]  
LIU J, 1991, ANESTH ANALG, V72, P785
[5]  
LOWE HJ, 1981, QUANTITATIVE PRACTIC, P157
[6]   THE SAFETY OF SEVOFLURANE IN HUMANS [J].
MAZZE, RI .
ANESTHESIOLOGY, 1992, 77 (06) :1062-1063
[7]   REACTION OF SEVOFLURANE AND ITS DEGRADATION PRODUCTS WITH SODA LIME - TOXICITY OF THE BY-PRODUCTS [J].
MORIO, M ;
FUJII, K ;
SATOH, N ;
IMAI, M ;
KAWAKAMI, U ;
MIZUNO, T ;
KAWAI, Y ;
OGASAWARA, Y ;
TAMURA, T ;
NEGISHI, A ;
KUMAGAI, Y ;
KAWAI, T .
ANESTHESIOLOGY, 1992, 77 (06) :1155-1164
[8]   STABILITY OF SEVOFLURANE IN SODA LIME [J].
STRUM, DP ;
JOHNSON, BH ;
EGER, EI .
ANESTHESIOLOGY, 1987, 67 (05) :779-781
[9]  
WALLIN RF, 1975, ANESTH ANALG, V54, P758
[10]   FACTORS AFFECTING THE RATE OF DISAPPEARANCE OF SEVOFLURANE IN BARALYME [J].
WONG, DT ;
LERMAN, J .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1992, 39 (04) :366-369